NASDAQ:TXMD - TherapeuticsMD Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$5.46 -0.53 (-8.85 %)
(As of 02/21/2019 04:54 AM ET)
Previous Close$5.99
Today's Range$5.46 - $6.08
52-Week Range$3.51 - $7.66
Volume5.11 million shs
Average Volume2.89 million shs
Market Capitalization$1.30 billion
P/E Ratio-14.76
Dividend YieldN/A

Analyst Ratings

TherapeuticsMD (NASDAQ:TXMD) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for TherapeuticsMD in the last 12 months. Their average twelve-month price target is $17.3333, suggesting that the stock has a possible upside of 217.46%. The high price target for TXMD is $27.00 and the low price target for TXMD is $11.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $17.3333$17.3333$15.25$14.00
Price Target Upside: 217.46% upside239.20% upside214.43% upside157.35% upside

TherapeuticsMD (NASDAQ:TXMD) Consensus Price Target History

Price Target History for TherapeuticsMD (NASDAQ:TXMD)

TherapeuticsMD (NASDAQ:TXMD) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/11/2019OppenheimerSet Price TargetBuy$14.00LowView Rating Details
1/21/2019Cantor FitzgeraldReiterated RatingBuy$27.00LowView Rating Details
8/15/2018JPMorgan Chase & Co.Set Price TargetBuy$11.00LowView Rating Details
3/9/2018Noble FinancialReiterated RatingBuyMediumView Rating Details
12/20/2017Deutsche BankSet Price TargetBuy$9.00HighView Rating Details
11/6/2017CowenReiterated RatingOutperform$13.00 ➝ $16.00N/AView Rating Details
9/26/2017Jefferies Financial GroupReiterated RatingBuy$15.00MediumView Rating Details
9/8/2017Morgan StanleyInitiated CoverageEqual Weight$6.00N/AView Rating Details
8/21/2017Stifel NicolausReiterated RatingBuy$20.00LowView Rating Details
7/11/2017CIBCUpgradeMarket Perform ➝ OutperformHighView Rating Details
(Data available from 2/21/2017 forward)
This page was last updated on 2/21/2019 by Staff

Featured Article: What is a front-end load?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel